These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21098861)

  • 1. Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB): a new potential therapeutic target in atherosclerosis?
    Dąbek J; Kułach A; Gąsior Z
    Pharmacol Rep; 2010; 62(5):778-83. PubMed ID: 21098861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear Factor-κB Activation as a Pathological Mechanism of Lipid Metabolism and Atherosclerosis.
    Yu XH; Zheng XL; Tang CK
    Adv Clin Chem; 2015; 70():1-30. PubMed ID: 26231484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear factor kappaB signaling in atherogenesis.
    de Winther MP; Kanters E; Kraal G; Hofker MH
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):904-14. PubMed ID: 15731497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear factor kappa B signaling in macrophage function and atherogenesis.
    Xanthoulea S; Curfs DM; Hofker MH; de Winther MP
    Curr Opin Lipidol; 2005 Oct; 16(5):536-42. PubMed ID: 16148538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-κB signaling at the crossroads of inflammation and atherogenesis: searching for new therapeutic links.
    Pateras I; Giaginis C; Tsigris C; Patsouris E; Theocharis S
    Expert Opin Ther Targets; 2014 Sep; 18(9):1089-101. PubMed ID: 25005042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pycnogenol attenuates atherosclerosis by regulating lipid metabolism through the TLR4-NF-κB pathway.
    Luo H; Wang J; Qiao C; Ma N; Liu D; Zhang W
    Exp Mol Med; 2015 Oct; 47(10):e191. PubMed ID: 26492950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pterostilbene, a novel natural plant conduct, inhibits high fat-induced atherosclerosis inflammation via NF-κB signaling pathway in Toll-like receptor 5 (TLR5) deficient mice.
    Zhang Y; Zhang Y
    Biomed Pharmacother; 2016 Jul; 81():345-355. PubMed ID: 27261612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of BMP Signaling and NF-κB Signaling on Osteoblastic Differentiation, Cancer Development, and Vascular Diseases--Is the Activation of NF-κB a Friend or Foe of BMP Function?
    Jimi E
    Vitam Horm; 2015; 99():145-70. PubMed ID: 26279375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classic and Novel Signaling Pathways Involved in Cancer: Targeting the NF-κB and Syk Signaling Pathways.
    Tang C; Zhu G
    Curr Stem Cell Res Ther; 2019; 14(3):219-225. PubMed ID: 30033874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide inhibitor of NF-κB translocation ameliorates experimental atherosclerosis.
    Mallavia B; Recio C; Oguiza A; Ortiz-Muñoz G; Lazaro I; Lopez-Parra V; Lopez-Franco O; Schindler S; Depping R; Egido J; Gomez-Guerrero C
    Am J Pathol; 2013 May; 182(5):1910-21. PubMed ID: 23597852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis.
    Gareus R; Kotsaki E; Xanthoulea S; van der Made I; Gijbels MJ; Kardakaris R; Polykratis A; Kollias G; de Winther MP; Pasparakis M
    Cell Metab; 2008 Nov; 8(5):372-83. PubMed ID: 19046569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of endothelial NF-κB signaling attenuates chronic intermittent hypoxia-induced atherosclerosis in mice.
    Song D; Fang G; Mao SZ; Ye X; Liu G; Miller EJ; Greenberg H; Liu SF
    Atherosclerosis; 2018 Mar; 270():68-75. PubMed ID: 29407890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kappaB as an integrator of diverse signaling pathways: the heart of myocardial signaling?
    Jones WK; Brown M; Ren X; He S; McGuinness M
    Cardiovasc Toxicol; 2003; 3(3):229-54. PubMed ID: 14555789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes.
    Oguiza A; Recio C; Lazaro I; Mallavia B; Blanco J; Egido J; Gomez-Guerrero C
    Diabetologia; 2015 Jul; 58(7):1656-67. PubMed ID: 25982245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases.
    Chen F; Castranova V; Shi X; Demers LM
    Clin Chem; 1999 Jan; 45(1):7-17. PubMed ID: 9895331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.
    Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS
    Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappa B signaling and carcinogenesis.
    Okamoto T; Sanda T; Asamitsu K
    Curr Pharm Des; 2007; 13(5):447-62. PubMed ID: 17348842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.
    Li Q; Sun W; Wang X; Zhang K; Xi W; Gao P
    Stem Cells Transl Med; 2015 Nov; 4(11):1294-301. PubMed ID: 26400926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.
    Brand K; Page S; Rogler G; Bartsch A; Brandl R; Knuechel R; Page M; Kaltschmidt C; Baeuerle PA; Neumeier D
    J Clin Invest; 1996 Apr; 97(7):1715-22. PubMed ID: 8601637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear transcription factor NF-kappa B: role in biology and medicine.
    Aggarwal BB; Takada Y; Shishodia S; Gutierrez AM; Oommen OV; Ichikawa H; Baba Y; Kumar A
    Indian J Exp Biol; 2004 Apr; 42(4):341-53. PubMed ID: 15088683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.